Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?

Authors : De Silva P, Aiello M, Gu-Trantien C, Migliori E, Willard-Gallo K, Solinas C
Year : 2021
Journal : Int J Cancer
Volume : 149
Pages : 31-41